Drugs / Echinaforce
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02971384 | Nov 2016 → Aug 2017 | viral respiratory tract infection | A. Vogel AG | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05002179 | Nov 2020 → May 2021 | common cold | A. Vogel AG | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Echinaforce | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05002179 ↗ |